| Literature DB >> 30948267 |
John P Pribis1, Libertad García-Villada2, Yin Zhai2, Ohad Lewin-Epstein3, Anthony Z Wang4, Jingjing Liu2, Jun Xia2, Qian Mei5, Devon M Fitzgerald6, Julia Bos7, Robert H Austin8, Christophe Herman9, David Bates9, Lilach Hadany3, P J Hastings10, Susan M Rosenberg11.
Abstract
Antibiotics can induce mutations that cause antibiotic resistance. Yet, despite their importance, mechanisms of antibiotic-promoted mutagenesis remain elusive. We report that the fluoroquinolone antibiotic ciprofloxacin (cipro) induces mutations by triggering transient differentiation of a mutant-generating cell subpopulation, using reactive oxygen species (ROS). Cipro-induced DNA breaks activate the Escherichia coli SOS DNA-damage response and error-prone DNA polymerases in all cells. However, mutagenesis is limited to a cell subpopulation in which electron transfer together with SOS induce ROS, which activate the sigma-S (σS) general-stress response, which allows mutagenic DNA-break repair. When sorted, this small σS-response-"on" subpopulation produces most antibiotic cross-resistant mutants. A U.S. Food and Drug Administration (FDA)-approved drug prevents σS induction, specifically inhibiting antibiotic-promoted mutagenesis. Further, SOS-inhibited cell division, which causes multi-chromosome cells, promotes mutagenesis. The data support a model in which within-cell chromosome cooperation together with development of a "gambler" cell subpopulation promote resistance evolution without risking most cells.Entities:
Keywords: Escherichia coli; RpoS (σ(S)) stress response; SOS response; antibiotic resistance; error-prone DNA polymerases; evolution; fluoroquinolones; reactive oxygen species; stress-induced mutagenesis
Mesh:
Substances:
Year: 2019 PMID: 30948267 PMCID: PMC6553487 DOI: 10.1016/j.molcel.2019.02.037
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970